| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.31▼ | 4.25▲ | 4.27▲ | 3.86▲ | 3.56▲ |
| MA10 | 4.28▲ | 4.27▲ | 4.16▲ | 3.47▲ | 3.17▲ |
| MA20 | 4.25▲ | 4.13▲ | 3.96▲ | 3.43▲ | 2.16▲ |
| MA50 | 4.25▲ | 3.85▲ | 3.54▲ | 2.98▲ | 1.55▲ |
| MA100 | 4.09▲ | 3.48▲ | 3.37▲ | 2.06▲ | 1.50▲ |
| MA200 | 3.86▲ | 3.38▲ | 3.66▲ | 1.61▲ | 6.28▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | -0.007▼ | 0.016▲ | 0.066▲ | 0.218▲ |
| RSI | 58.681▲ | 73.106▲ | 79.024▲ | 67.415▲ | 69.372▲ |
| STOCH | 89.071▲ | 63.757 | 84.490▲ | 86.851▲ | 44.498 |
| WILL %R | -15.385▲ | -13.514▲ | -8.197▲ | -4.736▲ | -44.500 |
| CCI | 87.632 | 67.783 | 92.775 | 197.099▲ | 76.640 |
|
Friday, April 10, 2026 09:40 AM
Detailed price information for An2 Therapeutics Inc (ANTX-Q) from The Globe and Mail including charting and trades.
|
|
Monday, March 30, 2026 11:51 PM
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today announced the initiation ...
|
|
Monday, March 16, 2026 04:59 PM
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/04/26 | 3.99 | 4.35 | 3.98 | 4.28 | 199,687 |
| 22/04/26 | 3.83 | 4.01 | 3.735 | 4.00 | 218,941 |
| 21/04/26 | 3.58 | 3.82 | 3.53 | 3.80 | 133,848 |
| 20/04/26 | 3.61 | 3.664 | 3.46 | 3.62 | 151,654 |
| 17/04/26 | 3.20 | 3.65 | 3.09 | 3.61 | 506,377 |
| 16/04/26 | 3.25 | 3.25 | 3.0294 | 3.14 | 313,332 |
| 15/04/26 | 2.91 | 3.27 | 2.872 | 3.26 | 1,050,565 |
| 14/04/26 | 3.01 | 3.11 | 2.94 | 2.98 | 561,138 |
| 13/04/26 | 3.00 | 3.07 | 2.93 | 3.01 | 390,461 |
| 10/04/26 | 3.00 | 3.34 | 2.90 | 2.97 | 573,486 |
|
|
||||
|
|
||||
|
|